Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
A Prospective Multicenter Study of the Effects of Plant-based Diets on Gut Microbiome and Derived Metabolites in Patients Affected by Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT07069751. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06203912. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07138209. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06732232. IPD Sharing: NO. Countries: 1. Publications: 0.
Lenalidomide, Adriamycin, Dexamethasone (RAD) Versus Lenalidomide, Bortezomib, Dexamethasone (VRD) for Induction in Newly Diagnosed Multiple Myeloma Followed by Response-adapted Consolidation and Lena
ClinicalTrials.gov study NCT01685814. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Determining The Impact Of Distance Reiki On Patient Reported QOL And Immunity Among Multiple Myeloma Patients
ClinicalTrials.gov study NCT04783038. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma
ClinicalTrials.gov study NCT05583617. IPD Sharing: YES. Countries: 6. Publications: 0.
Daratumumab, Ixazomib, & Dexamethasone or Daratumumab, Bortezomib, & Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT03942224. IPD Sharing: NO. Countries: 1. Publications: 0.
Application Study of 68Ga-NOTA-BCMA Nanoantibody Imaging in Multiple Myeloma
ClinicalTrials.gov study NCT07353554. IPD Sharing: NO. Countries: 1. Publications: 0.
Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02248402. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Eltrombopag Plus G-CSF on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing ASCT
ClinicalTrials.gov study NCT01286675. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT03767725. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Humanized CAR-T Cells of Anti-BCAM and Anti-CD19 Against Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04194931. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple Myeloma
ClinicalTrials.gov study NCT05013437. IPD Sharing: YES. Countries: 1. Publications: 0.
VitD3 Supplementation in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT05846880. IPD Sharing: NO. Countries: 1. Publications: 0.
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06106945. IPD Sharing: YES. Countries: 8. Publications: 0.
mRNA-2736 for Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
ClinicalTrials.gov study NCT05918250. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT01695590. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma
ClinicalTrials.gov study NCT01219010. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Iberdomide and Daratumumab As Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma
ClinicalTrials.gov study NCT06107738. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.